Antibiotic prescribing in hospitals: a social and behavioural scientific approach

被引:210
作者
Hulscher, Marlies E. J. L. [1 ]
Grol, Richard P. T. M. [1 ]
van der Meer, Jos W. M. [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
COMMUNITY-ACQUIRED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; ANTIMICROBIAL DRUG-USE; INSTITUTIONAL PROGRAM; AMERICA GUIDELINES; QUALITY; IMPLEMENTATION; ADHERENCE;
D O I
10.1016/S1473-3099(10)70027-X
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antibiotics have dramatically changed the prognoses of patients with severe infectious diseases over the past 50 years. However, the emergence and dissemination of resistant organisms has endangered the effectiveness of antibiotics. One possible approach to the resistance problem is the appropriate Use of antibiotic drugs for preventing and treating infections This Review describes how the volume and appropriateness of antibiotic use in hospitals vary between countries, hospitals, and physicians. At each specific level-cultural, contextual, and behavioural-we discuss the determinants that influence hospital antibiotic use and the possible improvement strategies to make it more appropriate. Changing hospital antibiotic use is a challenge of formidable complexity. On each level, many determinants play a part, so that the measures or strategies undertaken to improve antibiotic use need to be equally diverse. Although various strategies for improving antibiotic use are available, a programme with activities at all three levels is needed for hospitals. Evaluating these programme activities in a way that provides external validity of the conclusions is crucial.
引用
收藏
页码:167 / 175
页数:9
相关论文
共 80 条
[41]   Practices to improve antimicrobial use at 47 US hospitals: The status of the 1997 SHEA/IDSA position paper recommendations [J].
Lawton, RM ;
Fridkin, SK ;
Gaynes, RP ;
McGowan, JE .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (04) :256-259
[42]   How do you choose antibiotic treatment? [J].
Leibovici, L ;
Shraga, I ;
Andreassen, S .
BRITISH MEDICAL JOURNAL, 1999, 318 (7198) :1614-1616
[43]   Survey of antibiotic control policies in university-affiliated teaching institutions [J].
Lesar, TS ;
Briceland, LL .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (01) :31-34
[44]   Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use:: a time series analysis [J].
López-Lozano, JM ;
Monnet, DL ;
Yagüe, A ;
Burgos, A ;
Gonzalo, N ;
Campillos, P ;
Saez, M .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (01) :21-31
[45]   Antimicrobial stewardship programs in health care systems [J].
MacDougall, C ;
Polk, RE .
CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (04) :638-+
[46]   Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals [J].
MacKenzie, F. M. ;
Bruce, J. ;
Struelens, M. J. ;
Goossens, H. ;
Mollison, J. ;
Gould, I. M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (03) :269-276
[47]  
Majumdar Sumit R, 2004, Jt Comm J Qual Saf, V30, P387
[48]   Care bundles: the holy grail of infectious risk management in hospital? [J].
Marwick, Charis ;
Davey, Peter .
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (04) :364-369
[49]   The quality of health care delivered to adults in the United States [J].
McGlynn, EA ;
Asch, SM ;
Adams, J ;
Keesey, J ;
Hicks, J ;
DeCristofaro, A ;
Kerr, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2635-2645
[50]   Economic impact of antimicrobial resistance [J].
McGowan, JE .
EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :286-292